Search by Drug Name or NDC
NDC 24658-0760-16 Sodium Polystyrene Sulfonate 4.1 meq/g Details
Sodium Polystyrene Sulfonate 4.1 meq/g
Sodium Polystyrene Sulfonate is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PuraCap Laboratories, LLC. The primary component is SODIUM POLYSTYRENE SULFONATE.
Product Information
| NDC | 24658-0760 |
|---|---|
| Product ID | 24658-760_ae811fb8-9a78-496f-b710-663bc678f8e7 |
| Associated GPIs | 99450010002900 |
| GCN Sequence Number | 001194 |
| GCN Sequence Number Description | sodium polystyrene sulfonate POWDER ORAL |
| HIC3 | C1A |
| HIC3 Description | ELECTROLYTE DEPLETERS |
| GCN | 02890 |
| HICL Sequence Number | 013209 |
| HICL Sequence Number Description | SODIUM POLYSTYRENE SULFONATE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Polystyrene Sulfonate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Polystyrene Sulfonate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 4.1 |
| Active Ingredient Units | meq/g |
| Substance Name | SODIUM POLYSTYRENE SULFONATE |
| Labeler Name | PuraCap Laboratories, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202333 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24658-0760-16 (24658076016)
| NDC Package Code | 24658-760-16 |
|---|---|
| Billing NDC | 24658076016 |
| Package | 453.6 g in 1 JAR (24658-760-16) |
| Marketing Start Date | 2016-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.1425 |
| Pricing Unit | GM |
| Effective Date | 2022-11-23 |
| NDC Description | SODIUM POLYSTYRENE SULF POWDER |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis